Couple-Based Lifestyle Intervention to Prevent Type 2 Diabetes
- Conditions
- Prediabetic StatePreDiabetesOverweight and Obesity
- Interventions
- Behavioral: PreventT2 Together (Couple-based intervention)Behavioral: PreventT2 (Individual intervention)
- Registration Number
- NCT05695170
- Lead Sponsor
- University of Utah
- Brief Summary
The goal of this randomized pilot clinical trial is to describe the feasibility of a couple-based lifestyle intervention and the study protocol in preparation for a future definitive randomized clinical trial. Participants include individuals at risk for type 2 diabetes and their romantic partners.
The main objectives are:
1. To describe the feasibility of the couple-based intervention.
2. To describe the feasibility of the study protocol for use in a definitive trial.
Participating couples will be randomized to one of two year-long lifestyle intervention conditions: an individual curriculum or a couple-based curriculum.
Participants will complete assessments before and after the year-long intervention, as well as monthly during the intervention. Data will be collected on: feasibility, background, health behaviors, physical and mental health, and relationship functioning.
- Detailed Description
The goal of this randomized pilot clinical trial is to describe the feasibility of a couple-based lifestyle intervention and the study protocol in preparation for a future definitive randomized clinical trial. Participants include individuals at risk for type 2 diabetes and their romantic partners.
Prior to all study procedures, eligible participants will be required to complete an informed consent process and electronically sign a consent document. 12 eligible couples will be randomly assigned to either an individual lifestyle intervention (PreventT2) or a couple-based adaptation designed with input from a community advisory board (PreventT2 Together) (1:1). Both curricula have CDC approval for use in the National DPP and are delivered to small groups of participants over the course of 12 months.
Across conditions, participants will complete assessments before and after the year-long intervention, as well as monthly during the intervention. Data will be collected on: feasibility, background, health behaviors, physical and mental health, and relationship functioning.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 28
- BMI of ≥ 25 kg/m2 (≥ 23kg/m2 if Asian) AND 2) High risk for type 2 diabetes, based on 1+ of the following three:
-
CDC/American Diabetes Association Prediabetes Risk Test score ≥ 5
-
Blood test results indicative of prediabetes in the past year (i.e., fasting blood glucose 100-125 mg/dl; blood glucose of 140-199 mg/dl 2 hours after a 75 g glucose load; OR 6.4% ≥ HbA1c ≥ 5.7%)
-
Previous diagnosis of gestational diabetes (among women)
B. DPP
-
Diagnosis of type 1 diabetes or type 2 diabetes 2. Currently pregnant
AND
- Eligible for Study (Additional Criteria).
A. Study Inclusion Criteria:
- Living together for 1+ year
- Report being in a romantic relationship
- Conversational fluency in English
- Age 18 or older
- Interested in participating
B. Study Exclusion Criteria
- Diagnosis of another chronic disease (unless stable or with no major events/changes for 3+ months);
- Current medication for prediabetes or obesity;
- Current participation in lifestyle intervention for prediabetes or obesity;
- Past participation in the National DPP;
- Not comfortable participating in intervention together with partner.
- Eligibility criteria for "supporting partners":
A. Study Inclusion Criteria:
- Partner meets "target individual" eligibility criteria (per above)
- Living together for 1+ year
- Report being in a romantic relationship
- Conversational fluency in English
- Age 18 or older
- Interested in participating
B. Study Exclusion Criterion
- Not comfortable participating in intervention together with partner.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Couple-based intervention condition PreventT2 Together (Couple-based intervention) "PreventT2 Together" (couple-based adaptation of PreventT2; approved by the CDC in November 2022 as an Alternate Curriculum for use in the National DPP) Individual intervention condition PreventT2 (Individual intervention) "PreventT2" individual lifestyle intervention curriculum (2021 revised National DPP curriculum, freely available from the CDC)
- Primary Outcome Measures
Name Time Method Study protocol feasibility 1.5 years Participants will report on perceptions of the study protocol in a post-intervention qualitative joint couple interview that utilizes a semi-structured couple interview guide. The guide includes specific prompts focused on recruitment, randomization, and assessments.
In addition to these qualitative data collected from participants, data on recruitment feasibility will also be collected with an item on the contact form potential participants complete. Data on assessment feasibility will also be collected based on completion of measures and the length of time participants spend on these measures at each assessment.Couple-based intervention feasibility 1.5 years Participants will complete the Theoretical Framework of Acceptability-Based Questionnaire and two open-ended survey items developed by the research team monthly during the intervention and at post-intervention. Participants will also complete a post-intervention qualitative joint couple interview that utilizes a semi-structured couple interview guide. Lifestyle Coaches will also report on attendance, completion of weekly activity logs, and completion of make-up sessions.
The team of Lifestyle Coaches delivering PreventT2 Together will also complete open-ended items developed by the research team following each class. Lifestyle Coaches will also complete a measure of barriers to participation and lifestyle change they observed among the participants, as well as several measures based on implementation outcomes (i.e., Acceptability of Intervention Measure, Intervention Appropriateness Measure, Feasibility of Intervention Measure).
- Secondary Outcome Measures
Name Time Method Blood glucose. 1.5 years Assessed at pre-intervention by Clinical Research Unit medical staff: fasting blood glucose, HbA1c, 2-hr post glucose load (following 75 g OGTT).
Assessed at post-intervention by the A1c Now point-of-care system test: HbA1c.Depression. 1.5 years Assessed pre/post-intervention and monthly with the PROMIS Depression 8a item scale, which includes 8 statements such as "I felt worthless."
Relationship satisfaction. 1.5 years Assessed pre/post-intervention and monthly with the 16-item Couples Satisfaction Index (CSI), a measure of overall relationship satisfaction. Assessed daily during the pre/post-intervention 7-day accelerometer wear using a brief 4-item version of the CSI.
Physical activity. 1.5 years Assessed pre/post-intervention with the International Physical Activity Questionnaire (IPAQ)-Long and a 7-day accelerometer assessment. Assessed monthly with the IPAQ-7 day. Participants will also self-report minutes of moderate-to-vigorous physical activity over the past week at each attended intervention class.
IPAQ questionnaires assess self-reported walking, moderate intensity, and vigorous intensity physical activity as well as overall sedentary time. Accelerometers provide objective assessments of these constructs.Diet. 1.5 years Assessed pre/post-intervention with the Automated Self-Administered 24-hr diet assessment from the NCI (ASA-24). The ASA is a detailed 24-hour recall of food including portion sizes and preparation.
Assessed pre/post-intervention and monthly during the intervention with the Rapid Eating Assessment for Participants- Shortened Version (REAP-S), a brief measure of diet quality and content over an average week.BMI 1.5 years Weight in kilograms and height in meters will be measured pre-intervention by Clinical Research Unit staff in order to calculate BMI.
Anxiety. 1.5 years Assessed pre/post-intervention and monthly with the Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety 8a item scale. This 8-item measure includes statements such as "I felt fearful."
Affect. 1.5 years Participants will complete the Positive and Negative Affective Scale (PANAS) daily during the pre/post-intervention 7-day accelerometer wear. The PANAS assesses positive and negative affect over the last day with 20 items. Participants rate from 1 (very slightly to none at all) to 7 (extremely) the extent to which they experienced each item (e.g., "nervous") in the past day.
Partner support. 1.5 years Assessed pre/post-intervention and at months 3, 6, 9 during the intervention, with the Social support and Exercise Survey and the Social Support and Eating Habits Survey. These measures assess the amount of support individuals seeking to exercise regularly perceive from family members and the amount of support individuals seeking to improve their diet receive from family members.
Participants will also report on daily emotional and instrumental support during the pre/post-intervention 7-day accelerometer wear.Weight 1.5 years Weight in kilograms will be assessed pre-intervention by Clinical Research Unit staff and weight in pounds will also be collected before each intervention class by Lifestyle Coaches.
Weight in pounds will be collected post-intervention with a medical-grade scale.Sleep. 1.5 years Assessed pre/post-intervention and monthly with the Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance 8a item scale (SD) and the PROMIS Sleep-Related Impairment 8a item scale (SRI). Participants will also self-report their daily sleep during the 7-day pre/post-intervention accelerometer wear.
The SD assesses sleep quality with 8 statements including "my sleep was restless," and the SRI assesses the impact of poor sleep and sleepiness on daily behaviors with 8 statements including "I had problems during the day because of poor sleep." Item responses on both measures range from 1 (not at all) to 5 (very much).Waist circumference 1.5 years Waist circumference in inches will be measured pre-intervention by Clinical Research Unit staff.
Trial Locations
- Locations (1)
University of Utah
🇺🇸Salt Lake City, Utah, United States